Westhampton Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $592K | Buy |
1,127
+42
| +4% | +$22.1K | 0.31% | 80 |
|
|
2025
Q1 | $688K | Buy |
1,085
+22
| +2% | +$14K | 0.38% | 75 |
|
|
2024
Q4 | $757K | Buy |
1,063
+170
| +19% | +$121K | 0.39% | 72 |
|
|
2024
Q3 | $939K | Buy |
893
+15
| +2% | +$15.8K | 0.48% | 66 |
|
|
2024
Q2 | $923K | Hold |
878
| – | – | 0.5% | 62 |
|
|
2024
Q1 | $845K | Buy |
878
+15
| +2% | +$14.4K | 0.46% | 67 |
|
|
2023
Q4 | $758K | Hold |
863
| – | – | 0.45% | 66 |
|
|
2023
Q3 | $710K | Hold |
863
| – | – | 0.46% | 69 |
|
|
2023
Q2 | $620K | Buy |
863
+20
| +2% | +$14.4K | 0.4% | 68 |
|
|
2023
Q1 | $693K | Hold |
843
| – | – | 0.44% | 68 |
|
|
2022
Q4 | $608K | Buy |
843
+22
| +3% | +$15.9K | 0.41% | 71 |
|
|
2022
Q3 | $566K | Hold |
821
| – | – | 0.43% | 72 |
|
|
2022
Q2 | $485K | Buy |
821
+3
| +0.4% | +$1.77K | 0.34% | 84 |
|
|
2022
Q1 | $571K | Hold |
818
| – | – | 0.37% | 77 |
|
|
2021
Q4 | $517K | Hold |
818
| – | – | 0.32% | 83 |
|
|
2021
Q3 | $495K | Hold |
818
| – | – | 0.34% | 82 |
|
|
2021
Q2 | $457K | Buy |
818
+20
| +3% | +$11.2K | 0.3% | 86 |
|
|
2021
Q1 | $378K | Buy |
798
+24
| +3% | +$11.4K | 0.26% | 87 |
|
|
2020
Q4 | $374K | Hold |
774
| – | – | 0.28% | 81 |
|
|
2020
Q3 | $433K | Buy |
774
+24
| +3% | +$13.4K | 0.35% | 80 |
|
|
2020
Q2 | $468K | Hold |
750
| – | – | 0.41% | 67 |
|
|
2020
Q1 | $366K | Hold |
750
| – | – | 0.38% | 70 |
|
|
2019
Q4 | $282K | Hold |
750
| – | – | 0.23% | 91 |
|
|
2019
Q3 | $208K | Buy |
+750
| New | +$208K | 0.17% | 106 |
|